High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer

Overview of attention for article published in Cancer Management and Research, June 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 35 publications that cite this research output.

35

The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.

FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5

Article in International Journal of Molecular Sciences (March 2024)

DDX5 enhances HIF‐1 activity by promoting the interaction of HIF‐1α with HIF‐1β and recruiting the resulting heterodimer to its target gene loci

Article in Biology of the Cell (December 2023)

Role and therapeutic potential of DEAD-box RNA helicase family in colorectal cancer

Article in Frontiers in Oncology (October 2023)